Jeremy Brooks is a Cardiology physician. OpenAlex indexes 7 publications with 339 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9320 Park West Blvd
Knoxville, TN 379234301
Telephone
865-373-7100Provider last certified this registry record 13 Jul 2022.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20254 payments
- Medtronic, Inc.Program year20252 payments
- ABIOMEDProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.4%Statin22%Rosuvastatin Calcium60%Atorvastatin Calcium40%Part D≥84 patientsBeta blocker18%Metoprolol Succinate58%Carvedilol30%Metoprolol Tartrate6%Nebivolol Hcl5%Part D<11 patients+ 12 more classes in this area
Blood & clotting
14.6%Factor Xa inhibitor10.7%Eliquis89%Xarelto11%Part D<11 patientsP2Y12 inhibitor3.9%Clopidogrel72%Brilinta28%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hypertension as a Road to Treatment of Heart Failure with Preserved Ejection Fraction
Current Hypertension Reports
2020 - Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T<sub>1</sub> mapping
Journal of Magnetic Resonance Imaging
2013 - Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T<sub>1</sub>mapping
Journal of Magnetic Resonance Imaging
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”